Docetaxel Kabi is an anti-mitotic drug used for chemotherapy.

ATC-Code: L01CD02


Strength is denoted by dispoable cap color.

  • Docetaxel Kabi 20 mg/1 ml
  • Docetaxel Kabi 80 mg/4 ml
  • Docetaxel Kabi 120 mg/6 ml
  • Docetaxel Kabi 160 mg/8 ml
  • Docetaxel Kabi 180 mg/9 ml




Docetaxel Kabi is indicated for the treatment of patients with:

  • Locally advanced and metastatic
    • Breast cancer
    • Non-small cell lunger cancer
    • Gastrointestinal cancers
  • Advanced head and neck cancers
  • Hormone refactory metastatic prostate cancer

Product Information

Please note that this product may not be available in all countries due to different registration status.

Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.

If you require any information please contact your local organization.